Compare RGC & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGC | PIM |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 161.7M |
| IPO Year | 2021 | N/A |
| Metric | RGC | PIM |
|---|---|---|
| Price | $49.86 | $3.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 412.8K | 57.5K |
| Earning Date | 10-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $63.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $2.90 |
| 52 Week High | $83.60 | $3.28 |
| Indicator | RGC | PIM |
|---|---|---|
| Relative Strength Index (RSI) | 86.64 | 48.43 |
| Support Level | $20.70 | $3.32 |
| Resistance Level | $25.50 | $3.38 |
| Average True Range (ATR) | 4.57 | 0.06 |
| MACD | 2.24 | 0.01 |
| Stochastic Oscillator | 100.00 | 50.00 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.